RISPERIDONE
Total Payments
$16,042
Transactions
8
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $16,042 | 8 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $15,000 | 2 | 93.5% |
| Travel and Lodging | $792.96 | 4 | 4.9% |
| Food and Beverage | $248.56 | 2 | 1.5% |
Ad
Manufacturing Companies
- Teva Pharmaceuticals USA, Inc. $16,042
Product Information
- Type Drug
- Total Payments $16,042
- Total Doctors 2
- Transactions 8
About RISPERIDONE
RISPERIDONE is a drug associated with $16,042 in payments to 2 healthcare providers, recorded across 8 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..
Payment data is available from 2017 to 2017. In 2017, $16,042 was paid across 8 transactions to 2 doctors.
The most common payment nature for RISPERIDONE is "Consulting Fee" ($15,000, 93.5% of total).